Request Appointment
177 Fort Washington AveNew York, NY 10032
Fax+1 212-305-1754
Overview of Dr. Zucker
Dr. Jason Zucker is an infectious disease specialist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NewYork-Presbyterian/Allen Hospital. He received his medical degree from Rutgers New Jersey Medical School and has been in practice 9 years. He is one of 133 doctors at New York-Presbyterian Hospital and one of 45 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Infectious Disease. He has more than 100 publications and over 500 citings.
Education & Training
Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine/Pediatrics, 2010 - 2014- Rutgers New Jersey Medical SchoolClass of 2010
Certifications & Licensure
NY State Medical License 2015 - 2026
NJ State Medical License 2014 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- Atypical Mpox Cutaneous Presentation After Full Vaccination.Celine M Schreidah, Blair A Jenkins, Megan H Trager, Sameera Husain, Alexandra J Coromilas
The American Journal of Dermatopathology. 2025-05-01 - Identifying Provider Attitudes, Practices, and Barriers to Extra-Genital Testing for Neisseria Gonorrheae and Chlamydia Trachomatis Infections Among Adolescents and Yo...Roman Babayev, James DeCuir, Constance M Wiemann, Stefani Ricondo, Jason Zucker
The Journal of Adolescent Health. 2025-04-01 - A Qualitative Study of Doxycycline Postexposure Prophylaxis Knowledge, Attitudes, and Practices Among Health Care Providers in New York City.Paul A D'Avanzo, Joan Bosco, Caroline Carnevale, Jason Zucker
Sexually Transmitted Diseases. 2025-04-01
Press Mentions
There’s Finally a New Treatment for Drug-Resistant GonorrheaApril 18th, 2025- Newly FDA-Approved Antibiotic Gepotidacin May Effectively Treat GonorrheaApril 15th, 2025
- UTI Drug Offers Hope as New Gonorrhoea Treatment – Global StudyApril 15th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
